Kitamura K
J Int Med Res. 1981;9(3):215-21. doi: 10.1177/030006058100900312.
Two hundred and seventy patients suffering from the sequelae of different forms of brain injury have been treated orally with pyritinol 200 mg three times a day for a period of 6 weeks. It has been shown that, compared with placebo therapy, pyritinol produces statistically significant improvement in the clinical and psychoneurological manifestations. It is concluded that pyritinol is a drug of therapeutic benefit in the treatment of the sequelae of cerebral trauma.
270例患有不同形式脑损伤后遗症的患者接受了口服脑复新治疗,剂量为每日3次,每次200毫克,疗程为6周。结果表明,与安慰剂治疗相比,脑复新在临床和精神神经症状方面产生了具有统计学意义的改善。结论是,脑复新是治疗脑外伤后遗症的一种有益药物。